Thus, the DNA damage checkpoint is mediated by Rad9 and the replication checkpoint by Mrc1.
Rad53 phosphorylation (Figure 1 ) is a key step in the signal transduction cascade (Niyberg et al. 2002; Tercero and Diffley 2001) . Once activated, Rad53 phosphorylates protein targets including Dun1, which in turn phosphorylates proteins that lead to the upregulation of dNTP synthesis and transcription of DNA repair genes (Ahnesorg and Jackson 2007; Bashkirov et al. 2000; Huang et al. 1998; Zhao and Rothstein 2002) . Rad53 also acts either alone or in combination with Chk1 to arrest cells at G2/M, which prevents the premature segregation of damaged or broken chromosomes (reviewed in Branzei and Foiani 2009; Hsieh and Yamane 2008; Schleker et al. 2009 ).
Traditionally, the favored experimental approach to invoke the S-phase DNA damage checkpoint response is to treat cells with a high dose of a DNA damaging agent. While studies using a variety of chemicals and radiation treatments have provided a wealth of information on checkpoint pathways, controversy remains due, in part, to the different types of genotoxic agents used, varying dosages, and the wide range of lesions generated from even a single type of treatment. One controversy concerns the role of mismatch repair (MMR) in checkpoint activation. In the "signaling" model, MMR complexes are proposed to bind to DNA damage and form a protein scaffold that recruits sensor and effector checkpoint kinases, which facilitates phosphorylation and checkpoint activation (Adamson et al. 2005; Brown et al. 2003; Wang and Qin 2003; Yoshioka et al. 2006) . For the "processing" model, MMR DNA degradation activity is proposed to generate persisting ssDNA gaps that produce DSBs when encountered by advancing replication forks (Mojas et al. 2007) . These proposed roles of MMR in checkpoint activation, however, are paradoxical since checkpoint activation is a mechanism generally thought to help cells survive DNA damage, but the absence of MMR activity often renders mammalian cells less sensitive to killing by several DNA damaging agents (reviewed by Hsieh and Yamane 2008; Jiricny 2006) . The MMR status of cancer cells is important for therapeutic treatments because the absence of MMR can confer resistance (reviewed by Hsieh and Yamane 2008; Karran 2004) .
We report here a new approach to probe the role of MMR in the activation of the Sphase DNA damage checkpoint in S. cerevisiae by using a drug-sensitive DNA polymerase (pol)  (Li et al. 2005) . The yeast L612M-DNA pol , which was modeled on the bacteriophage T4 L412M-DNA pol (Reha-Krantz and Nonay 1994; Reha-Krantz et al. 1993) , has a Leu to Met substitution in the conserved Motif A sequence in the polymerase active center. Both the phage T4 and yeast mutant DNA pols are sensitive to the antiviral drug phosphonoacetic acid (PAA) (Reha-Krantz et al. 1993; P. Burgers, personal communication) .
Mounting evidence suggests that there is a division of labor at DNA replication forks with DNA pol  performing leading strand replication (Pursell et al. 2007 ) and DNA pol  serving as the lagging strand DNA pol (Nick McElhinny et al. 2008) ; thus, PAA is expected to inhibit lagging strand replication in cells expressing the L612M-DNA pol  (pol3-L612M cells). All other DNA pol  functions in DNA repair and recombination will also be compromised in the presence of PAA.
PAA-treated pol3-L612M cells arrest with the classic dumbbell morphology -a large mother cell and an attached daughter bud of similar size with a single nucleus located in the bud neck (Figure 2A) as observed for yeast treated with DNA damaging agents and for temperature-sensitive (ts) DNA pol  (cdc2) cells at the non-permissive temperature (Weinert and Hartwell 1993) . A fully functional MMR system is required to maintain viability of pol3-L612M cells exposed to PAA (Li et al. 2005) . pol3-L612M cells lacking any component of MMR except for Msh3, but including Exo1, are killed by very low concentrations of PAA (0.2 mg/ml). Although a large increase in mutations may be suspected of causing cell death, error catastrophe is unlikely in the case of EXO1 deficiency because only a modest increase in mutations is observed (Li et al. 2005 ).
Here we tested the hypothesis that the severe PAA-sensitivity of MMR-defective pol3-L612M cells is because MMR is needed to assist activation of an S-phase checkpoint.
MATERIALS AND METHODS
Media, strains, and the synthetic genetic array (SGA) screen: Cells were grown in either glucose or galactose standard synthetic media supplemented with amino acids; the type of sugar used did not affect PAA-sensitivity. PAA gradients were made as described previously (Li et al. 2005) . We find that spotting a constant number of cells (50 to 100) across a gradient is more useful for determining chemical sensitivity than assays in which serial dilutions of cells are spotted on a chemical-containing plate because high cell concentrations mask sensitivity.
All strains are described in Table1. Gene inactivation was done by replacement of an endogenous wild type gene with the kanMX cassette in POL3/pol3-L612M heterozygous diploids. Haploids containing the desired mutations were identified by tetrad dissection or by random spore analysis. All gene replacements were verified by PCR and the DNA pol  gene was sequenced to confirm the presence of the pol3-L612M allele.
The pol3-L612M query strainY6295 was constructed for the SGA analysis by transforming the Y5563 starter strain his31 met50) with the URA3 YIP-5 pol3-L612M plasmid (Li et al. 2005) . The transformant had a truncated pol3 gene and a full-length pol3-L612M gene as confirmed by DNA sequencing. The linked URA3 marker was retained to select for pol3-L612M double mutants. The SGA screen was performed in triplicate as described (Tong et al. 2001; Tong et al. 2004 samples of labeled cells were mixed with 0.2 ml of yeast carrier cells (10 9 cells/ml) plus 0.7 ml 20% TCA (trichloroacetic acid). The cells were pelleted and the supernatant was removed by aspiration. The cells were then suspended in 0.5 ml 0.1 M NaOH and then 0.5 ml of 15%
TCA was added to re-precipitate acid insoluble molecules including DNA. Suspensions were filtered through GF/C filters (Whatman) to capture DNA and the dried filters were counted in scintillation fluor.
In order to estimate the amount of DNA replication in PAA-arrested pol3-L612M In most experiments early exponential-phase cells were synchronized by adding -factor to a final concentration of 5 g/ml and incubating for 2.5 h. The cells were then pelleted by centrifugation, resuspended in fresh medium, pelleted again and then resuspended.
Cell morphology was monitored by microscopic examination of cells throughout the experiment. Cell viability was determined by comparing the cell titer from counting cells in a hemocytometer to the number of cells that can form visible colonies in 3 days.
Western blots: Standard procedures were followed. Cells were synchronized with  factor and then exposed to PAA for various times. Protein extracts were prepared by the TCA method. Briefly, cells from a 20 ml culture were washed first with water and then 20% trichloroacetic acid (TCA). The cell pellets were suspended in 100 l 20% TCA and stored at -20 ºC. Extracts were prepared by mixing an equal volume of glass beads with the TCAtreated cells and then vigorous vortexing until the majority of the cells were broken as determined by microscopic examination. The broken cells were transferred to a fresh tube and the glass beads were washed twice in 100 l of 5% TCA. Protein was pelleted by centrifugation and resuspended in 100 l Laemli buffer and neutralized by adding 50 l of 2M Tris. The sample was then boiled for 3 min and centrifuged. Gross chromosomal rearrangement (GCR) rates. GCR rates were determined as described (Motegi and Myung 2007 (Motegi and Myung 2007) . As a control, we determined the GCR rate for xrs2 cells and observed a rate of ~190  10 -9 , which is similar to the reported rate (Chen and Kolodner 1999) (Table 2 ). Rates were determined as described (Motegi and Myung 2007) ; the median rate is reported. Conrad and Newlon (1983) .
RESULTS

PAA-treated
In contrast to pol3-L612M cells, wild type (POL3) cells did not arrest in the presence of PAA, but progressed through the cell cycle at a slower doubling rate -~3.5 h compared to ~ 2.5 h in the absence of PAA (data not shown). Thus, PAA slows growth of wild type cells, but triggers cell cycle arrest in pol3-L612M cells.
PAA-triggered cell cycle arrest in pol3-L612M cells depends on the DNA damage S-phase checkpoint:
Both the replication and DNA damage S-phase checkpoints arrest cell cycle progression (Figure 1 ). The two checkpoints share several components in common, but a distinguishing feature is the dependence of the DNA damage checkpoint on Rad9 and the independence on Mrc1, which is required to mediate the replication checkpoint at stalled replication forks. In order to determine which checkpoint components are required for the PAA-triggered arrest of pol3-L612M cells and to uncover other DNA pol  interactions that affect PAA-sensitivity, we carried out a systematic genetic array (SGA) in which the pol3-L612M strain was crossed to ~ 4700 deletion mutants (Tong et al. 2001; Tong et al. 2004 ).
The double mutants were placed into two groups based on PAA-sensitivity.
For one group, PAA increased the slow growth phenotype as demonstrated by mrc1 pol3-L612M cells. PAA-sensitivity was measured by spotting cells on a plate with a gradient of PAA from 0 to 1 mg/ml. Increased PAA-sensitivity was observed for the double mutant, mrc1 pol3-L612M, compared to the single mutant strains at 3 days ( Figure 3A ), but was less apparent after 6 days incubation ( Figure 3B ). Deletion of TOF1, CTF18, CTF8, or CTF4 in the pol3-L612M background enhanced the slow growth or synthetically sick phenotype to the same extent as observed for deletion of MRC1 (Supporting Figure 1 ).
For the second group, cell death was observed at very low PAA concentrations as demonstrated for rad24 pol3-L612M cells ( Figure 3A ). This is the killing or synthetic lethal phenotype because growth was observed only at the lowest PAA concentration after 6 days and many abnormal multi-budded cells started to accumulate that were not observed for pol3-L612M cells. Viability declined to 25% by 10 h and was just 8% by 24 h (data not shown).
We also tested the possibility that DSBs produced by exposure of pol3-L612M cells to PAA increased gross chromosomal rearrangements (GCRs). An isogenic set of strains (Table   1 ) was constructed with a GCR reporter (Chen and Kolodner 1999; Motegi and Myung 2007; Myung et al. 2001) . GCRs are detected in the reporter by deletion of the nonessential end of the left arm of chromosome V, which contains the endogenous CAN1 gene and the nearby URA3 gene that was inserted into the nonessential HXT13 gene. The major class of GCRs observed by the simultaneous loss of the CAN1 and URA3 genes is terminal deletions of the end of chromosome V that are healed by de novo telomere addition (Myung et al. 2007) . A 20-fold increase in the GCR rate was observed for pol3-L612M cells exposed to PAA (Table 2) , which suggests that PAA-treatment induces DSBs and that repair is not completely error free.
The role of mismatch repair in protecting pol3-L612M cells exposed to PAA: We reported previously that deletion of MSH2, MLH1, PMS1, MSH6, or EXO1 (but not MSH3) markedly increases the PAA-sensitivity of pol3-L612M cells (Li et al. 2005) . The dependence of pol3-L612M cells on MMR was confirmed here ( Figure 6A ). In order to avoid complications produced by the high genetic instability of completely MMR-deficient pol3-L612M cells, msh6 pol3-L612M and exo1 pol3-L612M cells were examined. These cells are nearly as PAA-sensitive as completely MMR-deficient pol3-L612M cells, but are 80 to 100% viable in the absence of PAA and only a small increase in mutations is observed for the exo1 pol3-L612M strain (Li et al. 2005) . Cell growth and DNA replication were monitored as described above; PAA-treated msh6 pol3-L612M and exo1 pol3-L612M cells did not arrest cell growth or curb DNA replication as observed for checkpoint-deficient rad24 pol3-L612M cells ( Figures 3C and 3D ). Cell viability declined for PAA-treated msh6 pol3-L612M cells ( Figure 6B ) at a slower rate than observed for rad24 pol3-L612M cells ( Figure 3E ), but <5% cells were viable after 26 h exposure, which accounts for the observed PAA-induced killing/synthetic lethality phenotype. A similar pattern of PAA-sensitivity was observed for exo1 pol3-L612M cells (Li et al. 2005) .
Little if any Rad53 phosphorylation was observed for synchronized msh6 pol3-L612M cells over a 3 h exposure to 1 mg/ml PAA ( Figure 6C 
DUN1 is required for pol3-L612M cells to survive PAA:
If the S-phase DNA damage checkpoint is required for pol3-L612M cells to survive PAA, then downstream targets of Rad53 phosphorylation such as Dun1 are also expected to be required for viability.
As expected, dun1 pol3-L612M cells are as PAA-sensitive as rad24 pol3-L612M cells in which Rad53 is not activated (Li 2004 ). Thus, one or more Dun1 regulated activities is required for pol3-L612M cells to survive PAA. We have verified by the SGA screen that one Dun1 phosphorylation target -Rad55, which functions in DSB repair (4), is needed for pol3-L612M cells to survive PAA. Deletion of SML1, however, did not affect the PAA-sensitivity of pol3-L612M cells (Supporting Figure 3) . Sml1, an inhibitor of ribonucleotide reductase, is phosphorylated by activated Dun1, which relieves inhibition of ribonucleotide reductase and restarts dNTP synthesis (Chabes et al. 2003) . If increased dNTP synthesis alone were sufficient to rescue PAA-sensitivity then deletion of SML1 would be expected to decrease the PAA-sensitivity of pol3-L612M cells. As this was not observed, other Dun1 and damage checkpoint targets, likely in addition to inactivation of Sml1, are required for pol3-L612M cells to survive PAA.
POL32 is required for pol3-L612M cells to survive PAA: Deletion of the POL32
gene, which encodes the DNA pol  PCNA binding protein (Johansson et al. 2004 ), produced severe PAA-sensitivity; no growth was detected even at the lowest PAA concentrations tested (Supporting Figure 2) . Although POL32 is not essential in S. cerevisiae, a slow growth phenotype is observed in its absence and POL32 is essential in other eukaryotes. The strong dependence of pol3-L612M cells on Pol32 in the presence of PAA suggests that PCNA tethering of DNA pol  at replication forks and/or at other sites of DNA pol  action is required for viability. A role in maintaining the stability of stalled replication forks is another possibility because deletion of POL32 also increases HU sensitivity (Parsons et al. 2004) . (Figures 2-4) .
pol3-L612M cells have less dependence on Mrc1, the checkpoint adapter for stalled replication forks (Figure 3 ).
An important finding is that while DNA damage as detected by phosphorylated H2A
is observed for PAA-treated pol3-L612M cells after 1 h, only a little phosphorylated H2A is observed for PAA-treated msh6 pol3-L612M or exo1 pol3-L612M cells after 3 h (Figure 7 ).
Note that phosphorylated H2A is a well-known marker for DSBs, but there is a possibility that phosphorylated H2A is also produced in response to ssDNA. Detection of phosphorylated H2A is correlated with Rad53 phosphorylation, which is readily detected for PAA-treated pol3-L612M cells in 1 h (Figure 4 ), but not for PAA-treated msh6 pol3-L612M cells even after 3 h ( Figure 6C , upper panel) and only a small amount is observed for exo1 pol3-L612M cells ( Figure 6C , lower panel).
The dependency of PAA-treated pol3-L612M cells on Exo1 for survival suggests that ssDNA gaps produced by MMR are required for checkpoint activation; however, Exo1 is reported to play several roles including a structural role in stabilizing MMR complexes independent of its enzymatic role (Amin et al. 2001) . Outside of MMR, Exo 1 has many functions including processing and stabilizing stalled replication forks, controlling DNA damage checkpoint activation, and in recombination (Cotta-Ramusino et al. 2005; Segurado and Diffley 2008; Tran et al. 2004) . Furthermore, Exo1 is reported to function in checkpoint activation as part of the nucleotide excision repair pathway (Giannattasio et al. 2010) . Note, that DNA replication by DNA pol δ is also involved in these processes. Thus, the severe PAA-sensitivity of PAA-treated exo1 pol3-L612M cells may indicate the need of Exo1 function and/or the combined need of Exo1 and DNA pol δ function in multiple pathways.
The low level of Rad53 phosphorylation detected after 3 h exposure of exo1 pol3-L612M cells to PAA ( Figure 6C ) may be caused by DNA damage arising because of the absence of Exo1 in several different processes, but with regard to the PAA-sensitivity of pol3-L612M cells, Exo1 function is epistatic to Msh2 (Li et al. 2005) and, thus, Msh2 and Exo1 are working in the same pathway.
We propose that MMR creates ssDNA gaps that persist in PAA-treated pol3-L612M cells (Figure 9 ). DNA pol  is responsible for resynthesis of MMR-created ssDNA gaps (Kadyrov et al. 2007 ), but since PAA inhibits the L612M-DNA pol , gap-filling will be slowed. This proposal is supported by the observation that a low dose of HU, which is expected to provide an additional source of ssDNA, can partially substitute for MMR activity (Figure 8) . These data together suggest that MMR is required to increase ssDNA/DSBs above a threshold that is needed to activate the S-phase DNA damage checkpoint.
A threshold amount of ssDNA is required to activate S-phase checkpoints in order to prevent damage-like DNA structures present during normal DNA replication from accidentally triggering checkpoint activation (Shimada et al. 2002) . This reasoning certainly applies to lagging strand replication, in which individual Okazaki fragments are primed, elongated by DNA pol , and eventually joined together in reactions that also require DNA pol  (Jin et al. 2004) ; these steps will be compromised in PAA-treated pol3L612M cells. We propose that lagging strand replication is not monitored for ssDNA gaps or nicks that exist during the maturation of Okazaki fragments because these strand discontinuities are a normal aspect of lagging strand DNA replication; however, there are likely more gaps and nicks in the lagging strand of PAA-treated pol3-L612M cells than wild type cells and, more importantly, the gaps/nicks are predicted to heal slowly. Experiments presented here suggest that small strand discontinuities on the lagging strand fall under the radar of checkpoint surveillance, while larger gaps produced by MMR activity and DSBs are detected. S-phase checkpoint activation for PAA-treated pol3-L612M cells is life-saving because cell cycle arrest provides more time and additional resources (dNTPs, DSB repair enzymes) for the drug-sensitive L612M-DNA pol  to fully complete lagging strand replication and to repair DSBs before the cells enter mitosis.
We examined the possibility that hard-to-replicate DNA sequences are likely to be cells as demonstrated by the increased PAA-sensitivity observed when genes required for DSB repair -RAD51, RAD52, XRS2, or MRE11 genes are deleted (Figure 5 ). The slow growth/synthetic sickness phenotype that was observed for pol3-L612M cells deleted for MRC1, TOF1, CTF4, CTF18, or CTF8 (Figure 3 ; Supporting Figure 1 ) is also likely related to the function of these genes in sister chromatid cohesion that is required for recombination repair of DSBs (Xu et al. 2004) . Furthermore, since DNA pol  is required for the replication phase of homologous recombination (Maloisel et al. 2008) , PAA inhibition of the L612M-DNA pol  is expected to adversely affect recombination if reactions initiated are slow to be completed. This could explain the 20-fold increase in the GCR rate detected for PAA-treated pol3-L612M cells (Table 2 ).
In conclusion, we have provided additional evidence by studies of PAA-treated pol3-L612M cells for the proposal that a threshold level of DNA damage is required to activate the S-phase DNA damage checkpoint in yeast. Lagging strand replication problems produced by drug inhibition of the L612M-DNA pol  do not appear to provide sufficient DNA damage to trigger checkpoint activation even though continued cell cycle progression results in cell death. MMR activity, however, increases DNA damage within 1 h of PAA exposure, as reported by phosphorylated H2A (Figure 7) . In a related observation, Exo1 independent of MMR is observed in non-cycling cells to enlarge ssDNA gaps produced by the removal of UV lesions and these gaps are reported to drive Mec1 kinase activation (Giannattasio et al. 2010 ). Exo1-enlarged gaps in these experiments were detected as a "cloud" or smear of chromosomes that migrated only a short distance from the loading well during pulse field gel electrophoresis. We did not observe a chromosome cloud in PAA-treated pol3-L612M cells, which may indicate a lower level or shorter ssDNA gaps in our experiments compared to UVtreated cells in the experiments by Giannattasio et al. 2010 . Thus, Exo1 degradation as part of MMR in our studies or at sites of UV lesions appears to provide the means to engage the checkpoint response under conditions where checkpoint activation may not occur.
The absence of MMR and the checkpoint response in PAA-treated pol3-L612M cells has serious consequences for the few cells that survive. An unusually high mutation rate for production of PAA-resistant cells is observed for survivors ( Figure 6A ) that appears to diminish in the presence of HU (Figure 8 ). PAA-resistance is due to the acquisition of a second mutation that encodes an amino acid substitution that suppresses the PAA-sensitivity conferred by the L612M substitution (unpublished data). Furthermore, we observed many examples of unusual yeast cell morphology in PAA-treated MMR-deficient pol3-L612M cells (Figure 10 ). We cannot rule out the possibility that MMR is signaling checkpoint sensor kinases as proposed for mammalian cells, but because ssDNA is required for sensor kinases to bind DNA (Zou and Elledge, 2003) , we propose that MMR is needed primarily to produce ssDNA gaps. In order to explain the apparent interaction between MMR proteins and sensor kinases in mammalian cells, we suggest that MMR complexes remain associated with the ssDNA gaps (Figure 9 ). This is a reasonable proposal because some DNA repair proteins have been observed to remain associated with partially repaired DNA to reduce the chance of DNA repair intermediates becoming genotoxic lesions (Mol et al. 2000) .
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